Ross C. D. Buerlein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ross C. D. Buerlein has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Y. Wang
Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia
3 shared publications - Vanessa M. Shami
Univ Virginia Hlth Syst, Div Gastroenterol & Hepatol, Box 800708, Charlottesville, VA 22908 USA
3 shared publications - Alexander Podboy
Department of Internal Medicine, University of Virginia, Charlottesville, VA, USA
2 shared publications Andrew Y. Wang
Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia
2 shared publications- Anuragh R. Gudur
Department of Medicine, University of Virginia, Charlottesville, Virginia
2 shared publications - Calvin X. Geng
Department of Medicine, University of Virginia, Charlottesville, Virginia
2 shared publications
Latest Publications
- 29 March 2025
- Published by Springer Nature in Abdominal Radiology
- p. 1-26
Pancreatitis-related benign biliary strictures: a review of imaging findings and evolving endoscopic management
Biliary strictures can be secondary to a gamut of etiologies, most of which are malignant and the remaining related to a host of benign causes, including pancreatitis. Pancreatitis related benign biliary strictures (BBS) primarily involve the distal common bile duct (CBD) and can be seen in acute and chronic pancreatitis as well as their other forms, including necrotizing, groove, and autoimmune pancreatitis. Patients with pancreatitis related BBS present along a wide clinical spectrum that spans from an asymptomatic state to biliary obstruction, which not uncommonly facilitates additional workup for malignancy and endoscopic evaluation and treatment. Furthermore, the location and appearance of these strictures lends itself to various imitating benign and malignant etiologies. In this article, we will discuss the pathophysiology and clinicoradiologic features of pancreatitis related BBS while providing a review of an approach to their management focusing on endoscopic techniques.
- 29 March 2025
- Published by Springer Nature in Abdominal Radiology
- p. 1-26
Pancreatitis-related benign biliary strictures: a review of imaging findings and evolving endoscopic management
Biliary strictures can be secondary to a gamut of etiologies, most of which are malignant and the remaining related to a host of benign causes, including pancreatitis. Pancreatitis related benign biliary strictures (BBS) primarily involve the distal common bile duct (CBD) and can be seen in acute and chronic pancreatitis as well as their other forms, including necrotizing, groove, and autoimmune pancreatitis. Patients with pancreatitis related BBS present along a wide clinical spectrum that spans from an asymptomatic state to biliary obstruction, which not uncommonly facilitates additional workup for malignancy and endoscopic evaluation and treatment. Furthermore, the location and appearance of these strictures lends itself to various imitating benign and malignant etiologies. In this article, we will discuss the pathophysiology and clinicoradiologic features of pancreatitis related BBS while providing a review of an approach to their management focusing on endoscopic techniques.
- 27 June 2024
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 08 (04) , 256-262
Endoscopic Ablation of Perihilar Biliary Malignancies
Cholangiocarcinoma (CCA) is a malignancy arising from biliary epithelial cells and is subdivided based on the location within the biliary tree. The treatment of CCA differs based on the anatomical involvement within the biliary tree. Perihilar CCA (pCCA) arises between the cystic duct and the secondary branches of the right and left hepatic ducts. Surgical resection and liver transplantation offer the only hope for cure in pCCA, but, unfortunately, more than 80% of patients are considered surgically unresectable at the time of diagnosis resulting in a limited overall life expectancy of less than 1 year. For patients with surgically unresectable pCCA, treatment options are limited and include chemotherapy/chemoradiotherapy and biliary drainage via endoscopic stenting or percutaneous drainage with minimal overall survival benefits. However, endobiliary ablation options like photodynamic therapy (PDT), radiofrequency ablation (RFA), and, to a lesser degree, intraluminal brachytherapy have shown improvements in overall survival and improvements in stent patency and now should be considered for all cases of surgically unresectable pCCA. In fact, the 2023 American College of Gastroenterology (ACG) Clinical Guidelines on the diagnosis and management of biliary strictures recommend endobiliary ablation (PDT or RFA) for patients with surgically unresectable pCCA rather than stenting alone.
- 27 June 2024
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 08 (04) , 256-262
Endoscopic Ablation of Perihilar Biliary Malignancies
Cholangiocarcinoma (CCA) is a malignancy arising from biliary epithelial cells and is subdivided based on the location within the biliary tree. The treatment of CCA differs based on the anatomical involvement within the biliary tree. Perihilar CCA (pCCA) arises between the cystic duct and the secondary branches of the right and left hepatic ducts. Surgical resection and liver transplantation offer the only hope for cure in pCCA, but, unfortunately, more than 80% of patients are considered surgically unresectable at the time of diagnosis resulting in a limited overall life expectancy of less than 1 year. For patients with surgically unresectable pCCA, treatment options are limited and include chemotherapy/chemoradiotherapy and biliary drainage via endoscopic stenting or percutaneous drainage with minimal overall survival benefits. However, endobiliary ablation options like photodynamic therapy (PDT), radiofrequency ablation (RFA), and, to a lesser degree, intraluminal brachytherapy have shown improvements in overall survival and improvements in stent patency and now should be considered for all cases of surgically unresectable pCCA. In fact, the 2023 American College of Gastroenterology (ACG) Clinical Guidelines on the diagnosis and management of biliary strictures recommend endobiliary ablation (PDT or RFA) for patients with surgically unresectable pCCA rather than stenting alone.
- Open Access
- 20 June 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (4) , 483-493
Comparative accuracy of four guidelines to predict high-grade dysplasia or malignancy in surgically resected pancreatic intraductal papillary mucinous neoplasms: Small nuances between guidelines lead to vastly different results
Irene C. Perez, Andrew Bigelow, Vanessa M. Shami, Bryan G. Sauer, Andrew Y. Wang, Daniel S. Strand, Alexander J. Podboy, Todd W. Bauer, Victor M. Zaydfudim, Allan Tsung, Ross C. D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-049
- 20 June 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (4) , 483-493
Open AccessComparative accuracy of four guidelines to predict high-grade dysplasia or malignancy in surgically resected pancreatic intraductal papillary mucinous neoplasms: Small nuances between guidelines lead to vastly different results
Irene C. Perez, Andrew Bigelow, Vanessa M. Shami, Bryan G. Sauer, Andrew Y. Wang, Daniel S. Strand, Alexander J. Podboy, Todd W. Bauer, Victor M. Zaydfudim, Allan Tsung, Ross C. D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-049
- 1 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 1139-1145
Early safety of endoscopic sleeve gastroplasty in super obesity (body mass index > 50)
- 1 June 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (11) , 1139-1145
Early safety of endoscopic sleeve gastroplasty in super obesity (body mass index > 50)
- Open Access
- 15 February 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (2) , 144-154
Associations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis
Calvin X. Geng, Anuragh R. Gudur, Jagannath Kadiyala, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Alexander Podboy, Tri M. Le, Matthew Reilley, Victor Zaydfudim, Ross C.D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-136
- 15 February 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (2) , 144-154
Open AccessAssociations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis
Calvin X. Geng, Anuragh R. Gudur, Jagannath Kadiyala, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Alexander Podboy, Tri M. Le, Matthew Reilley, Victor Zaydfudim, Ross C.D. Buerlein. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-136
- 4 September 2023
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 34 (1) , 19-36
Endoscopic Diagnosis of Extra-Luminal Cancers
- 4 September 2023
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 34 (1) , 19-36
Endoscopic Diagnosis of Extra-Luminal Cancers
- Open Access
- 1 January 2023
- Published by AME Publishing Company in Annals of Laparoscopic and Endoscopic Surgery
- Vol. 9
Endoscopic resection of non-papillary neoplastic lesions of the duodenum: a narrative review of clinical application and techniques
Review Article Endoscopic resection of non-papillary neoplastic lesions of the duodenum: a narrative review of clinical application and techniques Ross C. D. Buerlein, Andrew Y. Wang
- 1 January 2023
- Published by AME Publishing Company in Annals of Laparoscopic and Endoscopic Surgery
- Vol. 9
Open AccessEndoscopic resection of non-papillary neoplastic lesions of the duodenum: a narrative review of clinical application and techniques
Review Article Endoscopic resection of non-papillary neoplastic lesions of the duodenum: a narrative review of clinical application and techniques Ross C. D. Buerlein, Andrew Y. Wang
- Open Access
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Gastrointestinal Endoscopy
- Vol. 14
Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know
The prevalence of pancreatic cysts has increased significantly over the last decade, partly secondary to increased quality and frequency of cross-sectional imaging. While the majority never progress to cancer, a small number will and need to be followed. The management of pancreatic cysts can be both confusing and intimidating due to the multiple guidelines with varying recommendations. Despite the differences in the specifics of the guidelines, they all agree on several high-risk features that should get the attention of any clinician when assessing a pancreatic cyst: presence of a mural nodule or solid component, dilation of the main pancreatic duct (or presence of main duct intraductal papillary mucinous neoplasm), pancreatic cyst size ⩾3–4 cm, or positive cytology on pancreatic cyst fluid aspiration. Other important criteria to consider include rapid cyst growth (⩾5 mm/year), elevated serum carbohydrate antigen 19-9 levels, new-onset diabetes mellitus, or acute pancreatitis thought to be related to the cystic lesion.
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Gastrointestinal Endoscopy
- Vol. 14
Open AccessManagement of pancreatic cysts and guidelines: what the gastroenterologist needs to know
The prevalence of pancreatic cysts has increased significantly over the last decade, partly secondary to increased quality and frequency of cross-sectional imaging. While the majority never progress to cancer, a small number will and need to be followed. The management of pancreatic cysts can be both confusing and intimidating due to the multiple guidelines with varying recommendations. Despite the differences in the specifics of the guidelines, they all agree on several high-risk features that should get the attention of any clinician when assessing a pancreatic cyst: presence of a mural nodule or solid component, dilation of the main pancreatic duct (or presence of main duct intraductal papillary mucinous neoplasm), pancreatic cyst size ⩾3–4 cm, or positive cytology on pancreatic cyst fluid aspiration. Other important criteria to consider include rapid cyst growth (⩾5 mm/year), elevated serum carbohydrate antigen 19-9 levels, new-onset diabetes mellitus, or acute pancreatitis thought to be related to the cystic lesion.